Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The role of tetramerization in p53 function

Oncogene volume 20, pages 2611–2617 (2001)Cite this article

Abstract

The tumour suppressor gene p53 is extensively studied for its importance in cancer. In its active conformation, p53 is tetrameric and one domain – the tetramerization domain – permits the oligomerization of this protein. Until recently, little attention was given to this domain because, in contrast to the DNA-binding domain, it is not often mutated in cancer. However, various experimental studies have shown evidence that the tetramerization domain is essential for DNA binding, protein–protein interactions, post-translational modifications, and p53 degradation. Moreover, single mutations in the tetramerization domain can inactivate the wild-type protein in a manner similar to that seen with mutations in the DNA-binding domain. Interestingly, the phenotype of several tetramerization domain mutants differs from that observed with DNA-binding domain mutants. In this review, current knowledge about the importance of the tetramerization domain to the function of p53 will be summarized.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Appella E, Anderson CW . 2000 Pathol. Biol. (Paris) 48: 227–245

  • Atz J, Wagner P, Roemer K . 2000 J. Cell. Biochem. 76: 572–584

  • Balagurumoorthy P, Sakamoto H, Lewis MS, Zambrano N, Clore GM, Gronenborn AM, Appella E, Harrington RE . 1995 Proc. Natl. Acad. Sci. USA 92: 8591–8595

  • Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C . 1993 Genes Dev. 7: 2565–2574

  • Bates S, Vousden KH . 1999 Cell. Mol. Life Sci. 55: 28–37

  • Blagosklonny MV . 2000 Faseb. J. 14: 1901–1907

  • Brachmann RK, Vidal M, Boeke JD . 1996 Proc. Natl. Acad. Sci. USA 93: 4091–4095

  • Chen J, Marechal V, Levine AJ . 1993 Mol. Cell. Biol. 13: 4107–4114

  • Chène P . 1998 J. Mol. Biol. 281: 205–209

  • Chène P . 1999 J. Mol. Biol. 288: 883–890

  • Chène P . 2000 Biotechniques 28: 240–242

  • Chène P, Bechter E . 1999a J. Mol. Biol. 288: 891–897

  • Chène P, Bechter E . 1999b J. Mol. Biol. 286: 1269–1274

  • Chène P, Mittl P, Grutter M . 1997 J. Mol. Biol. 273: 873–881

  • Cho Y, Gorina S, Jeffrey PD, Pavletich NP . 1994 Science 265: 346–355

  • Chou PY, Fasman GD . 1974 Biochemistry 13: 211–222

  • Clore GM, Ernst J, Clubb R, Omichinski JG, Kennedy WM, Sakaguchi K, Appella E, Gronenborn AM . 1995a Nat. Struct. Biol. 2: 321–333

  • Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM . 1994 Science 265: 386–391

  • Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM . 1995b Science 267: 1515–1516

  • Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH . 1999 J. Biol. Chem. 274: 18709–18714

  • Davison TS, Yin P, Nie E, Kay C, Arrowsmith CH . 1998 Oncogene 17: 651–656

  • Delphin C, Huang KP, Scotto C, Chapel A, Vincon M, Chambaz E, Garin J, Baudier J . 1997 Eur. J. Biochem. 245: 684–692

  • Di Como CJ, Gaiddon C, Prives C . 1999 Mol. Cell. Biol. 19: 1438–1449

  • Dobner T, Horikoshi N, Rubenwolf S, Shenk T . 1996 Science 272: 1470–1473

  • Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V, Oren M . 1988 Oncogene 3: 313–321

  • Frazier MW, He X, Wang J, Gu Z, Cleveland JL, Zambetti GP . 1998 Mol. Cell. Biol. 18: 3735–3743

  • Friedman PN, Chen X, Bargonetti J, Prives C . 1993 Proc. Natl. Acad. Sci. USA 90: 3319–3323

  • Gannon JV, Greaves R, Iggo R, Lane DP . 1990 EMBO J. 9: 1595–1602

  • Gotz C, Scholtes P, Prowald A, Schuster N, Nastainczyk W, Montenarh M . 1999 Mol. Cell. Biochem. 191: 111–120

  • Hainaut P, Hollstein M . 2000 Adv. Cancer Res. 77: 81–137

  • Hainaut P, Milner J . 1993 Cancer Res. 53: 4469–4473

  • Halazonetis TD, Davis LJ, Kandil AN . 1993 EMBO J. 12: 1021–1028

  • Halazonetis TD, Kandil AN . 1993 EMBO J. 12: 5057–5064

  • Halevy O, Hall A, Oren M . 1989 Mol. Cell. Biol. 9: 3385–3392

  • Hixon ML, Flores A, Wagner M, Gualberto A . 2000 Histol. Histopathol. 15: 551–556

  • Hollstein M, Hergenhahn M, Yang Q, Bartsch H, Wang ZQ, Hainaut P . 1999 Mutat. Res. 431: 199–209

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Hupp TR, Meek DW, Midgley CA, Lane DP . 1992 Cell 71: 875–886

  • Ikeda A, Sun X, Li Y, Zhang Y, Eckner R, Doi TS, Takahashi T, Obata Y, Yoshioka K, Yamamoto K . 2000 Biochem. Biophys. Res. Commun. 272: 375–379

  • Ishioka C, Shimodaira H, Englert C, Shimada A, Osada M, Jia LQ, Suzuki T, Gamo M, Kanamaru R . 1997 Biochem. Biophys. Res. Commun. 232: 54–60

  • Iwabuchi K, Li B, Bartel P, Fields S . 1993 Oncogene 8: 1693–1696

  • Jeffrey PD, Gorina S, Pavletich NP . 1995 Science 267: 1498–1502

  • Johnson CR, Morin PE, Arrowsmith CH, Freire E . 1995 Biochemistry 34: 5309–5316

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Kraiss S, Quaiser A, Oren M, Montenarh M . 1988 J. Virol. 62: 4737–4744

  • Kubbutat MH, Ludwig RL, Ashcroft M, Vousden KH . 1998 Mol. Cell. Biol. 18: 5690–5698

  • Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA, Deb S . 1998 Oncogene 16: 3169–3176

  • Lee W, Harvey TS, Yin Y, Yau P, Litchfield D, Arrowsmith CH . 1994 Nat. Struct. Biol. 1: 877–890

  • Levine AJ . 1997 Cell 88: 323–331

  • Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB . 1995 Ann. N. Y. Acad. Sci. 768: 111–128

  • Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S . 1997 Cancer Res. 57: 5137–5142

  • Liu X, Miller CW, Koeffler PH, Berk AJ . 1993 Mol. Cell. Biol. 13: 3291–3300

  • Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM, Camplejohn RS . 1997 Oncogene 14: 1869–1874

  • Lomax ME, Barnes DM, Hupp TR, Picksley SM, Camplejohn RS . 1998 Oncogene 17: 643–649

  • Maki CG . 1999 J. Biol. Chem. 274: 16531–16535

  • Malanga M, Pleschke JM, Kleczkowska HE, Althaus FR . 1998 J. Biol. Chem. 273: 11839–11843

  • Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin Jr WG . 2000 Nat. Genet. 25: 47–54

  • Marston NJ, Jenkins JR, Vousden KH . 1995 Oncogene 10: 1709–1715

  • Massimi P, Pim D, Bertoli C, Bouvard V, Banks L . 1999 Oncogene 18: 7748–7754

  • Mateu MG, Fersht AR . 1998 EMBO J. 17: 2748–2758

  • Mateu MG, Fersht AR . 1999 Proc. Natl. Acad. Sci. USA 96: 3595–3599

  • Mateu MG, Sanchez Del Pino MM, Fersht AR . 1999 Nat. Struct. Biol. 6: 191–198

  • McCormick F, Clark R, Harlow E, Tjian R . 1981 Nature 292: 63–65

  • McCoy M, Stavridi ES, Waterman JL, Wieczorek AM, Opella SJ, Halazonetis TD . 1997 EMBO J. 16: 6230–6236

  • McLure KG, Lee PW . 1996 Oncogene 13: 1297–1303

  • McLure KG, Lee PW . 1998 EMBO J. 17: 3342–3350

  • McLure KG, Lee PW . 1999 EMBO J. 18: 763–770

  • Meek DW . 1999 Oncogene 18: 7666–7675

  • Michalovitz D, Halevy O, Oren M . 1990 Cell 62: 671–680

  • Miller M, Lubkowski J, Rao JK, Danishefsky AT, Omichinski JG, Sakaguchi K, Sakamoto H, Appella E, Gronenborn AM, Clore GM . 1996 FEBS Lett. 399: 166–170

  • Milner J, Medcalf EA . 1990 J. Mol. Biol. 216: 481–484

  • Milner J, Medcalf EA . 1991 Cell 65: 765–774

  • Mittl PR, Chène P, Grutter MG . 1998 Acta Crystallogr. D. Biol. Crystallogr. 54: 86–89

  • Nagaich AK, Zhurkin VB, Durell SR, Jernigan RL, Appella E, Harrington RE . 1999 Proc. Natl. Acad. Sci. USA 96: 1875–1880

  • Nie Y, Li HH, Bula CM, Liu X . 2000 Mol. Cell. Biol. 20: 741–748

  • Oren M, Rotter V . 1999 Cell. Mol. Life Sci. 55: 9–11

  • Pavletich NP, Chambers KA, Pabo CO . 1993 Genes Dev. 7: 2556–2564

  • Roemer K . 1999 Biol. Chem. 380: 879–887

  • Rollenhagen C, Chène P . 1998 Int. J. Cancer 78: 372–376

  • Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D . 1997 Biochemistry 36: 10117–10124

  • Sakamoto H, Lewis MS, Kodama H, Appella E, Sakaguchi K . 1994 Proc. Natl. Acad. Sci. USA 91: 8974–8978

  • Sang BC, Chen JY, Minna J, Barbosa MS . 1994 Oncogene 9: 853–859

  • Schmieg FI, Simmons DT . 1988 Virology 164: 132–140

  • Selivanova G, Wiman KG . 1995 Adv. Cancer Res. 66: 143–180

  • Shaulian E, Zauberman A, Milner J, Davies EA, Oren M . 1993 EMBO J. 12: 2789–2797

  • Shieh SY, Ahn J, Tamai K, Taya Y, Prives C . 2000 Genes Dev. 14: 289–300

  • Soussi T, Caron de Fromentel C, May P . 1990 Oncogene 5: 945–952

  • Soussi T, Dehouche K, Beroud C . 2000 Hum. Mutat. 15: 105–113

  • Stavridi ES, Chehab NH, Caruso LC, Halazonetis TD . 1999 Protein Sci. 8: 1773–1779

  • Steele RJ, Thompson AM, Hall PA, Lane DP . 1998 Br. J. Surg. 85: 1460–1467

  • Stenger JE, Mayr GA, Mann K, Tegtmeyer P . 1992 Mol. Carcinog. 5: 102–106

  • Stenger JE, Tegtmeyer P, Mayr GA, Reed M, Wang Y, Wang P, Hough PV, Mastrangelo IA . 1994 EMBO J. 13: 6011–6120

  • Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM . 1999 EMBO J. 18: 1660–1672

  • Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M, Blandino G . 2000 J. Biol. Chem. 275: 29503–29512

  • Sturzbecher HW, Brain R, Addison C, Rudge K, Remm M, Grimaldi M, Keenan E, Jenkins JR . 1992 Oncogene 7: 1513–1523

  • Subler MA, Martin DW, Deb S . 1994 Oncogene 9: 1351–1359

  • Surridge C . 1994 Nature 372: 482

  • Tarunina M, Jenkins JR . 1993 Oncogene 8: 3165–3173

  • van Oijen MG, Slootweg PJ . 2000 Clin. Cancer Res. 6: 2138–2145

  • Varley JM, McGown G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell EL, Boyle J, Birch JM, Evans DG . 1996 Oncogene 12: 2437–2442

  • Wang Y, Farmer G, Soussi T, Prives C . 1995a Oncogene 10: 779–784

  • Wang Y, Reed M, Wang P, Stenger JE, Mayr G, Anderson ME, Schwedes JF, Tegtmeyer P . 1993 Genes Dev. 7: 2575–2586

  • Wang Y, Schwedes JF, Parks D, Mann K, Tegtmeyer P . 1995b Mol. Cell. Biol. 15: 2157–2165

  • Waterman JL, Shenk JL, Halazonetis TD . 1995 EMBO J. 14: 512–519

  • Zhang W, Guo XY, Deisseroth AB . 1994 Oncogene 9: 2513–2121

Download references

Acknowledgements

I would like to thank Dr S Ferrari for his critical reading of the manuscript.

Author information

Authors and Affiliations

  1. Novartis, Basel, K125 420, CH-4002, Switzerland

    Patrick Chène

Authors
  1. Patrick Chène
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chène, P. The role of tetramerization in p53 function. Oncogene 20, 2611–2617 (2001). https://doi.org/10.1038/sj.onc.1204373

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204373

Keywords

This article is cited by

Search

Advanced search

Quick links